This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Rana R. McKay, MD
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mCRPC Treatment
          Charles Ryan, MD
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Neal Shore, MD, FACS
        • A Patient Journey
          Alicia Morgans, MD, MPH
          Charles J. Ryan, MD
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
  • Transformative Evidence
    • mCRPC
      • CARD Trial
      • PROfound Study
    • mHSPC
      • ENZAMET Trial
    • nmCRPC
      • PROSPER Trial
    • Advanced Prostate Cancer
      • HERO Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Videos
    • Conference Coverage and Experts Group
      • Interviews with Experts at Conferences
        • ASCO GU 2021 Bladder and Kidney Cancer
        • ASCO GU 2021 Prostate Cancer
        • ASCO 2019
        • ASCO 2020
        • ASCO GU 2020
        • ESMO 2020
      • Exclusive Collaborations
        • APCCC 2019
        • LUGPA Annual Meeting 2019
        • PCF 2019
        • SNMMI Curriculum
    • UroToday Exclusives
      • Provocative Questions in Prostate Cancer
      • A Step Towards Personalized Medicine: PSMA PET Imaging in Prostate Cancer
      • Book Club
      • Clinical Trials in Progress
      • Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer
      • COVID-19 and Genitourinary Cancers Videos
      • Journal Club
      • Large Urology Group Practice Association (LUGPA)
      • Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos
    • Urologic Oncology
      • Prostate Cancer
        • Advances in Nuclear Medicine, PET, and Theranostics
        • Advanced Prostate Cancer
        • Cardiovascular Disease in Men with Prostate Cancer
        • CRPC with Bone Metastases
        • The Expert Voice
        • Imaging: Prostate Cancer
        • Localized Prostate Cancer
        • mCRPC
        • mHSPC
        • Molecular Diagnostics
        • Navigating Cancer
        • nmCRPC
        • The Patient Voice
        • Precision Medicine in Prostate Cancer
        • Prostate Cancer
      • Right Group
        • Bladder Cancer
          • Bladder Cancer
          • Bladder Cancer Expert Debates
          • Advanced Bladder Cancer
          • Non-Muscle Invasive Bladder Cancer
        • Kidney Cancer
          • Advanced Kidney Cancer
          • Renal Cancer
        • Upper Tract Urothelial Tumors
          • Upper Tract Urothelial Carcinoma
        • Pelvic Health & Reconstruction
          • Bladder Health
          • Indwelling Catheters
          • Intermittent Catheters
          • Nocturia & Lower Urinary Tract Conditions
        • Endourology
          • Endourology Today
          • Endourology
        • Testicular Cancer
          • Testicular Cancer
  • Journals
    • Everyday Urology - Oncology Insights
      Everyday Urology - Oncology Insights
      • From the Editor
      • Current Issue
      • Previous Issues
    • Prostate Cancer and Prostatic Diseases
      Prostate Cancer and Prostatic Diseases
      • From the Editor
      • Current Article
      • Previous Articles
  • Clinical Trials
    • Clinical Trials
      • Search Clinical Trials
    • From the Editor
      • Current Letter
      • Previous Letters
  • Conference Coverage
    • Advanced Prostate Cancer Consensus Conference (APCCC)
      • 2019 APCCC Meeting
    • American Society of Clinical Oncology (ASCO)
      • 2021 ASCO GU Symposium
      • 2020 Virtual Education Program
      • 2020 Annual Meeting
      • 2020 ASCO GU Symposium
    • American Urological Association (AUA)
      • 2020 Annual Meeting
    • ANZUP Mini Annual Scientific Meeting (ASM)
      • 2020 Virtual Annual Meeting
    • Bladder Cancer Advocacy Network (BCAN)
      • 2020 Think Tank Virtual Program
    • EAU Section of Oncological Urology
      • ESOU 2021
    • EMUC
      • 2020 Annual Meeting
    • European Association of Urology (EAU)
      • 2020 Annual Congress
    • European Society for Medical Oncology (ESMO)
      • 2020 Virtual Congress
    • Global Society of Rare GU Tumors
      • 2020 Meeting
    • International Bladder Cancer Network (IBCN)
      • 2020 Annual Virtual Meeting
    • NMIBC - Drug Development 2021
      • 2021 Annual Meeting
    • Prostate Cancer Academy
      • 2020 Annual Meeting
    • Société Internationale d'Urologie (SIU)
      • 2020 Annual Congress
    • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
      • 2021 Congress
      • 2020 Congress
    • Society of Urologic Oncology (SUO)
      • 2020 Annual Meeting
      • 2020 SUO - AUA Summer Webcast
    • Targeted Alpha Therapy (TAT)
      • 2019 Symposium
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Bladder Cancer
      • CRPC w/ Bone Metastases
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Upper Tract Tumors
      • Investigative Urology
      • Testicular Cancer
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
      • Urologic Catheters
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
    • COVID-19 and Genitourinary Cancers
      • COVID-19 and Genitourinary Cancers
  • Calendar
  1. UroToday Home
  2. Conference Highlights

ASCO GU 2021 Prostate Cancer

  • ASCO GU 2021: CTC Counts as a Biomarker of Prognosis and Response in Metastatic Castration-Resistant Prostate Cancer (mCRPC) from the CARD Trial
  • ASCO GU 2021: Back to Basics in Personalization: Returning to PTEN
  • ASCO GU 2021: 177Lu-PSMA-617 (LuPSMA) Versus Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel: Updated Results Including Progression-Free Survival and Patient-Reported Outcomes (TheraP ANZUP 1603)
  • ASCO GU 2021: Final Results from ACIS, a Randomized, Placebo-Controlled Double-Blind Phase 3 Study of Apalutamide and Abiraterone Acetate plus Prednisone (AAP) Versus AAP in Patients with Chemo-Naive Metastatic Castration-Resistant Prostate Cancer
  • ASCO GU 2021: Biomarker Analysis from a Randomized Phase II Study of Olaparib with or Without Cediranib in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
View all (83 articles)

ASCO GU 2021 Bladder Cancer

  • ASCO GU 2021: Role of Definitive Local Therapy After Complete Clinical Response to Neoadjuvant Chemotherapy
  • ASCO GU 2021: Optimal Radiologic Assessment After Systemic Therapy for Muscle-Invasive Bladder Cancer
  • ASCO GU 2021: Patient Perspective on Newly Diagnosed Muscle-Invasive Bladder Cancer: What Do I Hope the Doctor Will Address?
  • ASCO GU 2021: First Results from the Phase 3 CheckMate 274 Trial of Adjuvant Nivolumab vs Placebo in Patients Who Underwent Radical Surgery for High-Risk Muscle-Invasive Urothelial Carcinoma
  • ASCO GU 2021: Phase II Clinical Study of Concurrent Durvalumab and Radiation Therapy (DUART) Followed by Adjuvant Durvalumab in Patients with Localized Urothelial Cancer of Bladder: Results for Primary Analyses and Survival. BTCRC-GU15-023
View all (49 articles)

ASCO GU 2021 Kidney Cancer

  • ASCO GU 2021: MK-6482 in Patients with Patients with Clear Cell Renal Cell Carcinoma: Discussion
  • ASCO GU 2021: The CLEAR Study of Lenvatinib Plus Pembrolizumab or Everolimus vs Sunitinib and the SWOG 1500 Trial of Sunitinib, Cabozantinib, Crizotinib, and Savolitinib in Advanced Kidney Cancer: Discussion
  • ASCO GU 2021: The Oral HIF-2 α Inhibitor MK-6482 in Patients with Advanced Clear Cell Renal Cell Carcinoma (RCC): Updated Follow-up of a Phase I/II Study
  • ASCO GU 2021: Phase 3 Trial of Lenvatinib plus Pembrolizumab or Everolimus Versus Sunitinib Monotherapy as a First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (CLEAR Study)
  • ASCO GU 2021: Phase 2 Study of the Oral Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor MK-6482 in Combination with Cabozantinib in Patients with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
View all (38 articles)

ASCO GU 2021 Penile, Urethral, Testicular, and Adrenal Cancers

  • ASCO GU 2021: Australia and New Zealand Outcomes of High-Dose Chemotherapy and Stem Cell Transplantation for Relapsed or Refractory Germ Cell Tumors from 1999 to 2019: Multicenter Registry-Based Study with ABMTRR
  • ASCO GU 2021: Prediction Model for Brain Metastasis in Patients with Metastatic Germ-Cell Tumors Accounting for Size of Pulmonary Metastases
  • ASCO GU 2021: Longer Follow-up Data of Circulating miR371a-3p Expression Across the Spectrum of Germ Cell Tumors
  • ASCO GU 2021: Discussant: Results from the TRISST and SEMS Trials
  • ASCO GU 2021: Comprehensive Genomic Profiling in Patients with Relapsed/Refractory Germ Cell Tumors
View all (14 articles)

ASCO GU 2021 Press Releases

  • ANZUP Reports A New Class of Effective Therapy for Men with Metastatic Castration-Resistant Prostate Cancer
  • Weill Cornell Medicine Experts Presenting at 2021 ASCO GU
  • Foundation Medicine and Its Collaborators Announce New Study Results Further Demonstrating the Clinical Utility of Blood-Based Comprehensive Genomic Profiling in Patients with Advanced Prostate Cancer
  • Nivolumab in Combination with Cabozantinib Shows Sustained Survival and Response Rate Benefits as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma in the Phase 3 CheckMate -9ER Trial
  • Janssen Announces Treatment with Apalutamide Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
View all (8 articles)
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2021 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free